Summary by Moomoo AI
As of November 30, 2024, fosun pharma conducted multiple share repurchases of its H shares on the Hong Kong Stock Exchange, totaling 862,500 shares repurchased, which are held as treasury shares. The repurchase activities took place on November 1, 25, 26, and 27, with repurchase prices ranging from HK$14.03 to HK$14.92 per share. As a result of these repurchases, the total issued shares decreased to 545,606,500 shares, while the treasury shares increased to 6,334,000 shares. In terms of statutory/registered capital, the statutory capital of fosun pharma's H shares and A shares remain unchanged at RMB 551,940,500 and RMB 2,119,385,965 respectively, totaling RMB 2,671,326,465. The company confirmed that all repurchase activities were authorized by the board of directors and conducted in compliance with relevant laws and regulatory requirements. In the future, the company will continue to monitor market dynamics and adjust share structure as needed to optimize capital allocation.
